Matches in Wikidata for { <http://www.wikidata.org/entity/Q33676857> ?p ?o ?g. }
- Q33676857 description "2014 nî lūn-bûn" @default.
- Q33676857 description "2014 թուականի Մայիսին հրատարակուած գիտական յօդուած" @default.
- Q33676857 description "2014 թվականի մայիսին հրատարակված գիտական հոդված" @default.
- Q33676857 description "2014年の論文" @default.
- Q33676857 description "2014年論文" @default.
- Q33676857 description "2014年論文" @default.
- Q33676857 description "2014年論文" @default.
- Q33676857 description "2014年論文" @default.
- Q33676857 description "2014年論文" @default.
- Q33676857 description "2014年论文" @default.
- Q33676857 description "2014年论文" @default.
- Q33676857 description "2014年论文" @default.
- Q33676857 description "2014年论文" @default.
- Q33676857 description "2014年论文" @default.
- Q33676857 description "2014年论文" @default.
- Q33676857 description "2014년 논문" @default.
- Q33676857 description "article científic" @default.
- Q33676857 description "article scientific" @default.
- Q33676857 description "article scientifique (publié 2014)" @default.
- Q33676857 description "articol științific" @default.
- Q33676857 description "articolo scientifico" @default.
- Q33676857 description "artigo científico (publicado na 2014)" @default.
- Q33676857 description "artigo científico (publicado na 2014)" @default.
- Q33676857 description "artigo científico" @default.
- Q33676857 description "artikull shkencor" @default.
- Q33676857 description "artikulong pang-agham" @default.
- Q33676857 description "artykuł naukowy" @default.
- Q33676857 description "artículo científico publicado en 2014" @default.
- Q33676857 description "artículu científicu espublizáu en 2014" @default.
- Q33676857 description "bilimsel makale" @default.
- Q33676857 description "bài báo khoa học" @default.
- Q33676857 description "mokslinis straipsnis" @default.
- Q33676857 description "naučni članak" @default.
- Q33676857 description "scienca artikolo" @default.
- Q33676857 description "scientific article" @default.
- Q33676857 description "teaduslik artikkel" @default.
- Q33676857 description "tieteellinen artikkeli" @default.
- Q33676857 description "tudományos cikk" @default.
- Q33676857 description "vedecký článok" @default.
- Q33676857 description "vetenskaplig artikel" @default.
- Q33676857 description "videnskabelig artikel (udgivet 2014)" @default.
- Q33676857 description "vitenskapelig artikkel" @default.
- Q33676857 description "vitskapeleg artikkel" @default.
- Q33676857 description "vědecký článek" @default.
- Q33676857 description "wetenschappelijk artikel" @default.
- Q33676857 description "wissenschaftlicher Artikel" @default.
- Q33676857 description "επιστημονικό άρθρο" @default.
- Q33676857 description "мақолаи илмӣ" @default.
- Q33676857 description "мақолаи илмӣ" @default.
- Q33676857 description "наукова стаття, опублікована в травні 2014" @default.
- Q33676857 description "научна статия" @default.
- Q33676857 description "научная статья" @default.
- Q33676857 description "научни чланак" @default.
- Q33676857 description "научни чланак" @default.
- Q33676857 description "מאמר מדעי" @default.
- Q33676857 description "سائنسی مضمون" @default.
- Q33676857 description "مقالة علمية" @default.
- Q33676857 description "مقالهٔ علمی" @default.
- Q33676857 description "২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q33676857 description "บทความทางวิทยาศาสตร์" @default.
- Q33676857 description "სამეცნიერო სტატია" @default.
- Q33676857 name "Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada" @default.
- Q33676857 name "Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada" @default.
- Q33676857 name "Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada" @default.
- Q33676857 type Item @default.
- Q33676857 label "Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada" @default.
- Q33676857 label "Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada" @default.
- Q33676857 label "Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada" @default.
- Q33676857 prefLabel "Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada" @default.
- Q33676857 prefLabel "Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada" @default.
- Q33676857 prefLabel "Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada" @default.
- Q33676857 P1433 Q33676857-3213EED1-8363-4BD3-873B-5532A3863545 @default.
- Q33676857 P1476 Q33676857-933A3CBC-1AE9-418A-8118-88F2A4B6F0ED @default.
- Q33676857 P2093 Q33676857-30B5CE0E-A8A8-4387-98FF-AA9B595F96E4 @default.
- Q33676857 P2093 Q33676857-6297C6C4-A1BB-4D16-A59F-FE57F9AEA5F1 @default.
- Q33676857 P2860 Q33676857-17D35F83-8B83-4741-8EF2-57469A5A0D97 @default.
- Q33676857 P2860 Q33676857-1BDBEC77-A399-40FC-BD07-0557FBDA051B @default.
- Q33676857 P2860 Q33676857-95959BA5-6FC3-4031-B45A-3DCEA2143FA9 @default.
- Q33676857 P2860 Q33676857-A56A5BA6-A7F5-4EE4-8FDA-0770C43EE273 @default.
- Q33676857 P2860 Q33676857-A6E3FCA0-CC71-4128-9038-B691EA470753 @default.
- Q33676857 P2860 Q33676857-F46CB8E2-063B-4544-B36A-05121E282EAA @default.
- Q33676857 P2888 Q33676857-BCB15D53-C1EF-475D-A5A7-A098C70EA2D5 @default.
- Q33676857 P304 Q33676857-AC03B5A3-C30F-4F38-B11B-771124292D95 @default.
- Q33676857 P31 Q33676857-A54E8724-C7B0-4260-9233-EDF6DE31D08A @default.
- Q33676857 P356 Q33676857-27E3B055-75AE-4526-ADAC-117773704133 @default.
- Q33676857 P433 Q33676857-2E792787-87C1-4E9F-8994-7C170F5E55A1 @default.
- Q33676857 P478 Q33676857-AB9C43BB-00CA-4707-A093-4E819BD361A8 @default.
- Q33676857 P50 Q33676857-228784B9-E049-4070-B8E8-513BA3801ACB @default.
- Q33676857 P577 Q33676857-ECC83552-4F17-4EA4-A7CC-914DB93A59D0 @default.
- Q33676857 P5875 Q33676857-1946D4C1-23F8-46C2-A08D-ACE8A558FFFF @default.
- Q33676857 P6179 Q33676857-C15975DA-3139-44F5-BB9F-56E8281508CD @default.
- Q33676857 P698 Q33676857-314175BD-336C-4102-A9D8-F00CDC1A6F0A @default.
- Q33676857 P921 Q33676857-81C0E1CE-E31A-4878-8442-6A62CF967944 @default.
- Q33676857 P932 Q33676857-A5367D53-1976-4AA0-8FFA-B2EF9904E116 @default.
- Q33676857 P356 1710-1492-10-23 @default.
- Q33676857 P698 24872821 @default.
- Q33676857 P1433 Q15727057 @default.
- Q33676857 P1476 "Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada" @default.
- Q33676857 P2093 "Arthur S Zbrozek" @default.
- Q33676857 P2093 "William C Gerth" @default.